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Salt transport defects in CF lungs predispose to overwhelming and fatal respiratory infection caused by Pseudomonas aeruginosa. Motility of
this organism is central to pathogenesis in a number of settings. Incubation of numerous strains of P. aeruginosa with hypertonic saline caused a
concentration-dependent decrease in bacterial motility. Reduction of P. aeruginosa virulence through this effect may contribute to clinical efficacy
of hypertonic saline aerosols in CF patients.
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Chronic pulmonary infection with Pseudomonas aeruginosa
is a hallmark of cystic fibrosis (CF). P. aeruginosa motility and
swimming are likely to represent important factors in CF
pulmonary disease progression and severity. P. aeruginosa
lacking flagella are significantly less virulent in rodent models
of pneumonia, including defective motility, immuno-stimula-
tion, and adaptation. [1,2] Flagella-deficient P. aeruginosa are
also less damaging in murine models of chronic corneal and
burn infections. [3–5] Bacterial chemotaxis may promote
migration of P. aeruginosa towards more favorable sites of
infection, improved nutrient availability, and away from host
defense and clearance: all potential mechanisms pertinent to the
CF lung.
Numerous clinical reports [6–8] including two recent
randomized, placebo-controlled trials from two independent
centers [9,10] indicate beneficial effects of hypertonic saline
(HS, 7% NaCl) aerosols in CF lung disease. This intervention
was shown to restore airway surface liquid (ASL) depth and
mucociliary clearance. [10] However, the results of the studies⁎ Corresponding author. Tel.: +1 205 934 6344; fax: +1 205 934 7593.
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doi:10.1016/j.jcf.2007.11.009presented a paradox: a 48 week treatment with 4 milliliters (ml)
hypertonic saline aerosolized twice daily to CF subjects led to a
dramatic decrease in acute pulmonary exacerbations of CF (and
diminished need for antibiotics), but had minimal effect on
pulmonary function (FEV1 improved only 68 ml and was
statistically significant only when analyzed as a composite
endpoint). [9] A shorter (two week, higher dose intensity) trial
of 5 ml HS 4 times daily led to a larger increase in pulmonary
function (113 ml). However, when amiloride was co-adminis-
tered with HS (intended to stabilize a presumed increase in ASL
depth by blocking NaCl reabsorption through ENaC), the
benefits of HS on both pulmonary function and mucociliary
clearance were essentially lost. [10].
Evenmodest increases in extracellularNaCl (400–500mOsm/L)
have been shown to arrest swimming and impair the fliC regulatory
element in E. coli [11,12]. Similarly, 500 millimolar NaCl in an
environmental isolate of P. aeruginosa abolished motility and
diminished flagellar gene synthesis. [13] Daily aerosols of up to
20ml HS (2178mOsm/L) as tested in recent clinical trials are likely
to increase the salt of the pulmonary secretions by 2–3 fold over
weeks to months of daily aerosolization.
As one test of possible effects of high salt solutions on
P. aeruginosa motility, swim plates at increasing NaCl con-
centrations were establishedwith 0.4% agar in LBmedia (Fig. 1).d by Elsevier B.V. All rights reserved.
Fig. 1. P. aeruginosa spreading is blocked by hypertonic saline. Panel A: Depicts a standard swim motility plate in which agar (0.4% in LB media) has been inoculated
either with motility competent (PA01) or incompetent (fliC mutant) strain. The fliC mutant was devoid of swim behavior at all salt concentrations and time points
studied. (not shown). Panel B: Time dependent swimming from the inoculation site at varying salt concentrations was studied at 24, 48, and 72 hours. PA01, FRD1
(mucoid) strain lacking fliC, FRD1 (algT(U)), or FRD1 parent, and two non-mucoid (NM) clinical strains are depicted. Motility was measured by the area of spread
under each condition. Concentrations of saline ≥2% or b0.9% inhibited P. aeruginosa motility. Panel C: The growth of P. aeruginosa (PA01) is also impaired by
exposure to high salt concentration. Growth curves for 7%, 2%, and 0.9% NaCl liquid cultures are shown. By 24 hours (Panel C, lower), growth is nearly ablated in all
strains in 7% salt. However, 2% salt appears normal despite pronounced effects on motility.
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motile at all time points and all salt conditions. The common
laboratory strain PA01 (www.pseudomonas.com), the CF clinical
isolate FRD1, and several other strains were also studied. An
isogenic FRD fliC::Gm mutant was constructed via allelic
exchange and sucrose counterselection. [14] An algT(U)::Tn501
was previously derived by transposon mutagenesis [15] and
confirmed by Southern blot. All these strains, as well as patient
derived P. aeruginosa (isolated and typed by the clinical
microbiology laboratory at Children's Hospital of Alabama and
judged non-mucoid (NM) by conventional phenotyping) exhib-
ited a strong dose and time dependence of motility on ambient
salt concentration (Panel B). At the highest salt concentration
tested (7%), both growth and motility of P. aeruginosa were
abolished, but effects were limited to bacterial swimming in 2%
NaCl (Panel C).
The observation that high salt impairs P. aeruginosa motility
and inhibits growth suggests that the clinical benefit attributable
to HS aerosols might be due in part to these effects. Although
Elkins et al. showed no effects on P. aeruginosa colony countsduring long term HS administration, P. aeruginosa motility was
not evaluated and our data suggest that lower NaCl may have
significant effects on motility. Normal motility is crucial to
P. aeruginosa pathogenesis in rodent models of pneumonia
[1,2], as well as other models of infection. [3–5] Clinical studies
to monitor salt accumulation in the CF mucus itself (i.e. the site
of P. aeruginosa infection; rather than within ASL as examined
previously) and tests of flagellar structure and function (known
to be inhibited by high salt in E. coli [11,12]), should be
considered as part of future clinical trials of the HS intervention
in CF individuals. Confirmation of increased salt in CF mucus
following HS administration could validate the potential for HS
to confer these beneficial effects. [16].
Our findings do not connote effects on Pseudomonas mo-
tility as the only mechanism by which HS ameliorates CF lung
disease. Rather, our data implicate impairment of bacterial mo-
tility as a potential contributor to the HS intervention. Elkins
et al. did not describe a subgroup analysis regarding uninfected
CF individuals. However, a 1.5 ml deposition (approximately
30%) of a 5 ml dose of HS [9] represents an estimate of lower
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airway epithelia can adjust to a fluid load of this magnitude,
much less is known regarding clearance rates for NaCl
deposited within purulent secretions in CF lungs (i.e. where
mucus plaques represent a predominant site of bacterial
infection), or the mechanisms by which added salt is managed
within CF secretions, themselves. The present findings indicate
the importance of additional endpoints addressing motility and
other microbial virulence factors following HS aerosolization.
The mechanism by which increased salt or osmolarity
disrupt motility function is likely to be multifactorial. Inorganic
polyphosphate (polyP), a regulator of the bacterial networks
responding to environmental stress, also controls motility of
numerous bacterial pathogens [18,19], although the chronic
effects of salt administration on polyP and motility have not
been examined previously. [20] Because flagellar activity
appears to be necessary for biofilm formation in P. aeruginosa
[21], it is possible that the effects of salt described here could
also influence a functional step in the biofilm adaptation and
quorum sensing response. Clinical interventions specifically
targeting both chemotaxis and flagellar machinery have not
been studied and should be considered as a potential therapeutic
target for inhibiting P. aeruginosa in CF and other lung
diseases.
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